(University of Lincoln) A new antibiotic hailed as the 'last line of defence' in the battle against drug-resistant superbugs such as MSRA and VRE could provide new treatment options, thanks to a UK Government grant of almost £500,000. Over the next year scientists will develop an arsenal of synthetic versions of a naturally-occurring antibiotic called teixobactin which could then be turned into a drug fit for human use.
